DOW Combat Readiness – Medical Research Program Translational Research Award
About
Summary: The fiscal year 2026 (FY26) Combat Readiness – Medical Research Program (CRRP) Translational Research Award (TRA) supports hypothesis-driven innovative, high-impact translational research that will accelerate the movement of promising ideas and/or technologies in trauma care into solutions to maximize casualty survivability, improve patient care closer to the point of injury and/or trauma care guidelines. Preliminary data are required. Research using well-validated animal models is allowed. Distinctive Features: • **NEW for FY26** An investigator may be named as the Principal Investigator (PI) on only one FY26 CRRP TRA application. • Research supported by the FY26 CRRP TRA must represent a mature, translational research effort with a minimum biomedical technology readiness level (TRL) of 4 or knowledge readiness level (KRL) of 4.
The DOW Combat Readiness – Medical Research Program Translational Research Award supports innovative researchers and medical professionals developing translational solutions to advance trauma care and casualty survivability. This grant funds hypothesis-driven research that bridges the gap between promising scientific concepts and practical clinical applications, with a focus on improving patient care at the point of injury and enhancing trauma care guidelines. Researchers must demonstrate preliminary data and can utilize well-validated animal models in their work. The program is designed for mature translational research efforts that have reached a minimum biomedical technology readiness level (TRL) of 4 or knowledge readiness level (KRL) of 4. This is an excellent opportunity for medical researchers, trauma surgeons, military medicine specialists, and biomedical innovators seeking to commercialize or implement breakthrough trauma solutions. The FY26 cycle introduces a new restriction: investigators can serve as Principal Investigator on only one FY26 CRRP TRA application, encouraging focused research efforts. If you're developing cutting-edge trauma care technologies or methodologies backed by solid preliminary evidence, this grant can provide critical support to accelerate your research from concept to real-world clinical impact.
Funding Facts
● Applications openDeadline
November 18, 2026
Who can apply
Last verified July 5, 2026 · Source: Grants.gov
Grant Details
Funding Range
Varies by cycle
Deadline
2026-11-18
Grant Type
federal
Application Cycle
Annual
Best For
Trauma care researchers, military medicine specialists, biomedical innovators, medical institutions conducting translational research
Frequently Asked Questions
Who is eligible for DOW Combat Readiness – Medical Research Program Translational Research Award?
Specific eligibility criteria are not fully detailed in available information. However, the program targets researchers conducting hypothesis-driven translational research in trauma care and casualty survivability. Applicants must have preliminary data and propose research at a minimum biomedical technology readiness level (TRL) of 4 or knowledge readiness level (KRL) of 4. For complete eligibility requirements, including institutional affiliations, citizenship status, and other specific criteria, visit the official DOW or Defense Health Agency website.
How much funding does DOW Combat Readiness – Medical Research Program Translational Research Award provide?
Specific funding amounts for the FY26 cycle have not been provided in available information. Award amounts may vary based on research scope and requirements. Contact the Department of War or the Defense Health Agency directly, or consult the official grant announcement for funding ranges and budget guidelines.
How do I apply for DOW Combat Readiness – Medical Research Program Translational Research Award?
Applications for the DOW Combat Readiness – Medical Research Program Translational Research Award typically follow federal grant procedures. The FY26 application deadline is November 18, 2026. Applicants should prepare proposals that clearly demonstrate preliminary data, hypothesis-driven research objectives, and how their work advances trauma care solutions. For detailed application instructions, submission portals, and required documentation, visit the official Defense Health Agency or DOW grants website. Note that PIs can only be named on one FY26 CRRP TRA application.
What can DOW Combat Readiness – Medical Research Program Translational Research Award funding be used for?
Funding supports hypothesis-driven, high-impact translational research that accelerates the movement of promising ideas and technologies in trauma care into practical solutions. Approved uses include research to maximize casualty survivability, improve patient care at the point of injury, and enhance trauma care guidelines. Research using well-validated animal models is permitted. The research must represent a mature translational effort meeting minimum readiness level standards (TRL 4 or KRL 4). For specifics on allowable costs and restrictions, consult the official grant guidelines.
Last updated: July 5, 2026